{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T21:26:19Z","timestamp":1784841979498,"version":"3.55.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015250","name":"NIHR Bristol Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015250","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.diabres.2020.108266","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T20:47:51Z","timestamp":1591822071000},"page":"108266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review"],"prefix":"10.1016","volume":"165","author":[{"given":"Awadhesh Kumar","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2020.108266_b0005","unstructured":"World Health Organization: Coronavirus disease (COVID-19), Situation Report \u2013 115, Data as received by WHO from national authorities by 10:00 CEST, 14 May 2020. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200514-covid-19-sitrep-115.pdf?sfvrsn=3fce8d3c_4 [accessed May 14, 2020]."},{"key":"10.1016\/j.diabres.2020.108266_b0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s005920170017","article-title":"Bacterial pneumonia: comparison between diabetics and non-diabetics","volume":"38","author":"Akbar","year":"2001","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.diabres.2020.108266_b0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijid.2016.06.015","article-title":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis","volume":"49","author":"Badawi","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.diabres.2020.108266_b0020","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/cid\/ciu226","article-title":"Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients","volume":"59","author":"Al-Tawfiq","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diabres.2020.108266_b0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3201\/eid2201.151340","article-title":"Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans","volume":"22","author":"Alraddadi","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"10.1016\/j.diabres.2020.108266_b0030","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.2337\/dc09-2215","article-title":"Diabetes and the severity of pandemic influenza A (H1N1) infection","volume":"33","author":"Allard","year":"2010","journal-title":"Diabet Care"},{"issue":"6","key":"10.1016\/j.diabres.2020.108266_b0035","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1464-5491.2006.01861.x","article-title":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS","volume":"23","author":"Yang","year":"2006","journal-title":"Diabet Med"},{"issue":"10223","key":"10.1016\/j.diabres.2020.108266_b0040","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2020.108266_b0045","doi-asserted-by":"crossref","first-page":"m1091","DOI":"10.1136\/bmj.m1091","article-title":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","volume":"368","author":"Chen","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2020.108266_b0050","doi-asserted-by":"crossref","unstructured":"Chen T, Dai Z, Mo P, et al. Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study. J Gerontol Ser A Biol Sci Med Sci 2020:pii: glaa089. doi: 10.1093\/gerona\/glaa089. [Epub ahead of print].","DOI":"10.1093\/gerona\/glaa089"},{"issue":"5","key":"10.1016\/j.diabres.2020.108266_b0055","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","article-title":"Kidney disease is associated with in-hospital death of patients with COVID-19","volume":"97","author":"Cheng","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2020.108266_b0060","doi-asserted-by":"crossref","unstructured":"Feng Y, Ling Y, Bai T, et al. COVID-19 with different severity: a multi-center study of clinical features. Am J Respirat Crit Care Med 2020. doi: 10.1164\/rccm.202002-0445OC. [Epub ahead of print].","DOI":"10.1164\/rccm.202002-0445OC"},{"key":"10.1016\/j.diabres.2020.108266_b0065","doi-asserted-by":"crossref","unstructured":"Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020 [Published online March 27, 2020]. doi: 10.1001\/jamacardio.2020.1017.","DOI":"10.1001\/jamacardio.2020.1017"},{"key":"10.1016\/j.diabres.2020.108266_b0070","doi-asserted-by":"crossref","first-page":"e3319","DOI":"10.1002\/dmrr.3319","article-title":"Diabetes is a risk factor for the progression and prognosis of COVID-19","author":"Guo","year":"2020","journal-title":"Diabet\/Metabol Res Rev"},{"issue":"10223","key":"10.1016\/j.diabres.2020.108266_b0075","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2020.108266_b0080","doi-asserted-by":"crossref","unstructured":"Lian J, Jin X, Hao S, et al. Analysis of epidemiological and clinical features in older patients with corona virus disease 2019 (COVID-19) out of Wuhan. Clin Infect Dis 2020 [pii: ciaa242]. doi: 10.1093\/cid\/ciaa242 [Epub ahead of print].","DOI":"10.1093\/cid\/ciaa242"},{"key":"10.1016\/j.diabres.2020.108266_b0085","unstructured":"Liang WH, Guan WJ, Li CC, et al. Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicenter) and outside Hubei (non-epicenter): a nationwide analysis of China. Eurn Respirat J 2020 [online ahead of print]."},{"issue":"9","key":"10.1016\/j.diabres.2020.108266_b0090","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/CM9.0000000000000744","article-title":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province","volume":"133","author":"Liu","year":"2020","journal-title":"Chin Med J"},{"issue":"7","key":"10.1016\/j.diabres.2020.108266_b0095","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/jmv.25783","article-title":"Clinical features and treatment of COVID\u201019 patients in northeast Chongqing","volume":"92","author":"Wan","year":"2020","journal-title":"J Med Virol"},{"issue":"11","key":"10.1016\/j.diabres.2020.108266_b0100","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2020.108266_b0105","doi-asserted-by":"crossref","unstructured":"Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis 2020. pii: ciaa272. doi: 10.1093\/cid\/ciaa272 [Epub ahead of print]","DOI":"10.1093\/cid\/ciaa272"},{"key":"10.1016\/j.diabres.2020.108266_b0110","doi-asserted-by":"crossref","unstructured":"Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020. Published online March 13, 2020. doi: 10.1001\/jamainternmed.2020.0994.","DOI":"10.1001\/jamainternmed.2020.0994"},{"key":"10.1016\/j.diabres.2020.108266_b0115","doi-asserted-by":"crossref","unstructured":"Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020. doi: 10.1111\/all.14238. [Epub ahead of print]","DOI":"10.1111\/all.14238"},{"key":"10.1016\/j.diabres.2020.108266_b0120","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.diabres.2020.108266_b0125","first-page":"145","article-title":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China","volume":"41","author":"Epidemiology Working Group for Ncip Epidemic Response","year":"2020","journal-title":"Chin J Epidemiol"},{"key":"10.1016\/j.diabres.2020.108266_b0130","doi-asserted-by":"crossref","unstructured":"CDC COVID-19 Response Team. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 \u2013 United States, February 12\u2013March 28, 2020. MMWR Morb Mortal Wkly Rep 2020:382\u20136.","DOI":"10.15585\/mmwr.mm6913e2"},{"key":"10.1016\/j.diabres.2020.108266_b0135","first-page":"06","article-title":"Baseline Characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy","volume":"06","author":"Grasselli","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.diabres.2020.108266_b0140","doi-asserted-by":"crossref","unstructured":"Docherty AB, Harrison EM, Green CA, Hardwick H, Pius R, Norman L, et al. Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO clinical characterisation protocol. medRxiv preprint doi: https:\/\/doi.org\/10.1101\/2020.04.23.20076042.","DOI":"10.1101\/2020.04.23.20076042"},{"key":"10.1016\/j.diabres.2020.108266_b0145","doi-asserted-by":"crossref","unstructured":"Preito-Alhambra D, Ballo E, Coma E, Mora N, Aragon M, Prats-Uribe A, et al. Hospitalization and 30-day fatality in 121,263 COVID-19 outpatient cases. medRxiv preprint doi: https:\/\/doi.org\/10.1101\/2020.05.04.20090050.","DOI":"10.1101\/2020.05.04.20090050"},{"key":"10.1016\/j.diabres.2020.108266_b0150","doi-asserted-by":"crossref","unstructured":"Bello-Chavolla OY, Bahena-Lopez JP, Antonio-Villa NE, Vargas-Vazquez A, Gonzalez-Diaz A, Mequez-Salinas A, et al. Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico. medRxiv preprint doi: https:\/\/doi.org\/10.1101\/2020.04.20.20072223.","DOI":"10.1101\/2020.04.20.20072223"},{"key":"10.1016\/j.diabres.2020.108266_b0155","doi-asserted-by":"crossref","DOI":"10.1007\/s00392-020-01626-9","article-title":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China","author":"Li","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.diabres.2020.108266_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis","author":"Yang","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.diabres.2020.108266_b0165","first-page":"e35","article-title":"Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis","volume":"8","author":"Emami","year":"2020","journal-title":"Arch Acad Emerg Med"},{"key":"10.1016\/j.diabres.2020.108266_b0170","doi-asserted-by":"crossref","first-page":"104371","DOI":"10.1016\/j.jcv.2020.104371","article-title":"Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis","volume":"127","author":"Hu","year":"2020","journal-title":"J Clin Virol"},{"key":"10.1016\/j.diabres.2020.108266_b0175","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1001\/jama.2017.7596","article-title":"Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013","volume":"317","author":"Wang","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2020.108266_b0180","doi-asserted-by":"crossref","unstructured":"Chen YM, Gong X, Wang L, Guo J. Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis. medRxiv 2020; Preprint.","DOI":"10.1101\/2020.03.25.20043133"},{"key":"10.1016\/j.diabres.2020.108266_b0185","doi-asserted-by":"crossref","first-page":"104354","DOI":"10.1016\/j.jcv.2020.104354","article-title":"Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome","volume":"127","author":"Roncon","year":"2020","journal-title":"J Clin Virol"},{"key":"10.1016\/j.diabres.2020.108266_b0190","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.18632\/aging.103000","article-title":"Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis","volume":"12","author":"Wang","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.diabres.2020.108266_b0195","article-title":"Is diabetes mellitus associated with mortality and severity of COVID-19? A metaanalysis","author":"Kumar","year":"2020","journal-title":"Diabet Metabol Syndrome: Res Rev"},{"key":"10.1016\/j.diabres.2020.108266_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2020.04.018","article-title":"Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia \u2013 A systematic review, meta-analysis, and meta-regression","author":"Huang","year":"2020","journal-title":"Diabet Metabolic Syndrome: Clin Res Rev"},{"key":"10.1016\/j.diabres.2020.108266_b0205","article-title":"Diabetes is a risk factor for the progression and prognosis of COVID-19","author":"Guo","year":"20203319","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.diabres.2020.108266_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cmet.2020.04.021","article-title":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes","volume":"31","author":"Zhu","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.diabres.2020.108266_b0215","doi-asserted-by":"crossref","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors or mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Published Online March 2020;9. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3.","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"10.1016\/j.diabres.2020.108266_b0220","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention","author":"Wu","year":"2020","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.diabres.2020.108266_b0225","first-page":"1","article-title":"Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States","author":"Bode","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.diabres.2020.108266_b0230","doi-asserted-by":"crossref","unstructured":"Williamson E, Walker AJ, Bhaskaran KJ, Bacon S, Bates C, Morton CE, et al. OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. MedRxiv preprint. doi: https:\/\/doi.org\/10.1101\/2020.05.06.20092999.","DOI":"10.1101\/2020.05.06.20092999"},{"issue":"3","key":"10.1016\/j.diabres.2020.108266_b0235","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.dsx.2020.03.002","article-title":"Clinical considerations for patients with diabetes in times of COVID-19 epidemic","volume":"14","author":"Gupta","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.diabres.2020.108266_b0240","doi-asserted-by":"crossref","unstructured":"Bornstein SR, Rubino Francesco, Khunti K, Mingrone G, Hopkins D, Birkenfeld A, et al. Practical recommendation. Lancet Diabet Endocrinol. DOI: https:\/\/doi.org\/10.1016\/S2213-8587(20)30152-2.","DOI":"10.1016\/S2213-8587(20)30152-2"},{"key":"10.1016\/j.diabres.2020.108266_b0245","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.dsx.2020.04.004","article-title":"Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations","volume":"14","author":"Singh","year":"2020","journal-title":"Diabet Metabolic Syndrome: Clin Res Rev"},{"key":"10.1016\/j.diabres.2020.108266_b0250","doi-asserted-by":"crossref","unstructured":"Sinclair A, Dhatariya K, Burr O, Nagi D, Higgins K, Hopkins D, et al. Guidelines for the management of diabetes in care homes during the Covid\u201019 pandemic. Diabet Med. https:\/\/doi.org\/10.1111\/dme.14317.","DOI":"10.1111\/dme.14317"},{"key":"10.1016\/j.diabres.2020.108266_b0255","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12020-020-02294-5","article-title":"COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology","volume":"68","author":"Puig-Domingo","year":"2020","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.diabres.2020.108266_b0260","doi-asserted-by":"crossref","first-page":"dgaa148","DOI":"10.1210\/clinem\/dgaa148","article-title":"Our response to COVID-19 as endocrinologists and diabetologists","volume":"105","author":"Kaiser","year":"2020","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.diabres.2020.108266_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108146","article-title":"Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?","volume":"163","author":"Pal","year":"2020","journal-title":"Diabet Res Clin Pract"},{"issue":"1","key":"10.1016\/j.diabres.2020.108266_b0270","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13054-019-2346-4","article-title":"Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies","volume":"23","author":"Liang","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.diabres.2020.108266_b0275","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00228-019-02786-y","article-title":"Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis","volume":"76","author":"Zhang","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.diabres.2020.108266_b0280","doi-asserted-by":"crossref","first-page":"646e51","DOI":"10.1111\/resp.13486","article-title":"Reduced mortality from lower respiratory tract disease in adult diabetic patients treated with metformin","volume":"24","author":"Mendy","year":"2019","journal-title":"Respirology"},{"key":"10.1016\/j.diabres.2020.108266_b0285","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12931-019-1035-9","article-title":"Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease","volume":"20","author":"Ho","year":"2019","journal-title":"Respir Res"},{"issue":"2014","key":"10.1016\/j.diabres.2020.108266_b0290","first-page":"603409","article-title":"Pioglitazone upregulates angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced nonalcoholic steatohepatitis","volume":"14","author":"Zhang","year":"2014","journal-title":"Sci World J"},{"key":"10.1016\/j.diabres.2020.108266_b0295","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1111\/bcp.13288","article-title":"Use of oral antidiabetic agents and risk of community-acquired pneumonia: a nested case\u2013control study","volume":"83","author":"Gorricho","year":"2017","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.diabres.2020.108266_b0300","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/thx.2010.152777","article-title":"Long-term use of thiazolidinediones and the associated risk of pneumonia or lower respiratory tract infection: systematic review and meta-analysis","volume":"66","author":"Singh","year":"2011","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.diabres.2020.108266_b0305","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jss.2014.03.007","article-title":"Pioglitazone attenuates lung injury by modulating adipose inflammation","volume":"189","author":"Kutsukake","year":"2014","journal-title":"J Surg Res"},{"key":"10.1016\/j.diabres.2020.108266_b0310","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/ATVBAHA.108.175687","article-title":"Pioglitazone Inhibits the expression of inflammatory cytokines from both monocytes and lymphocytes in patients with impaired glucose tolerance","volume":"28","author":"Zhang","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.diabres.2020.108266_b0315","doi-asserted-by":"crossref","first-page":"109776","DOI":"10.1016\/j.mehy.2020.109776","article-title":"Can pioglitazone be potentially useful therapeutically in treating patients with COVID-19?","volume":"140","author":"Carboni","year":"2020","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.diabres.2020.108266_b0320","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/infdis\/153.5.944","article-title":"Effects of sulfonylurea compounds on pneumocystis carinii","volume":"153","author":"Hughes","year":"1986","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diabres.2020.108266_b0325","doi-asserted-by":"crossref","first-page":"15142","DOI":"10.1038\/s41598-018-33483-y","article-title":"Comparative safety of dipeptidyl peptidase-4 inhibitors versus sulfonylureas and other glucose-lowering therapies for three acute outcomes","volume":"8","author":"Gamble","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabres.2020.108266_b0330","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnaa011","article-title":"Coronavirus infections and Type 2 diabetes\u2014shared pathways with therapeutic implications","author":"Drucker","year":"2020","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.diabres.2020.108266_b0335","doi-asserted-by":"crossref","first-page":"155e68","DOI":"10.1080\/22221751.2020.1713705","article-title":"Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus","volume":"9","author":"Kleine-Weber","year":"2020","journal-title":"Emerg Microb Infect"},{"issue":"7440","key":"10.1016\/j.diabres.2020.108266_b0340","doi-asserted-by":"crossref","first-page":"251e4","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.diabres.2020.108266_b0345","doi-asserted-by":"crossref","first-page":"601e4","DOI":"10.1080\/22221751.2020.1739565","article-title":"Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26","volume":"9","author":"Vankadari","year":"2020","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.diabres.2020.108266_b0350","article-title":"Role of Dipeptidyl peptidase 4 inhibitors in diabetic patients with coronavirus-19 infection","author":"Chen","year":"2020","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.diabres.2020.108266_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108125","article-title":"COVID-19 and diabetes: Can DPP4 inhibition play a role?","volume":"162","author":"Iacobellis","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2020.108266_b0360","unstructured":"Dapagliflozin in respiratory failure in patients with COVID-19 (DARE-19). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04350593."},{"key":"10.1016\/j.diabres.2020.108266_b0365","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.dsx.2020.04.024","article-title":"Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis","volume":"14","author":"Cure","year":"2020","journal-title":"Diabet Metabolic Syndrome: Clin Res Rev"},{"issue":"10","key":"10.1016\/j.diabres.2020.108266_b0370","doi-asserted-by":"crossref","first-page":"3559e69","DOI":"10.1210\/en.2014-1685","article-title":"Activation of the GLP-1 receptor by liraglutide increases ACE2 expression, reversing right ventricle hypertrophy, and improving the production of SP-A and SP-B in the lungs of type 1 diabetes rats","volume":"156","author":"Roman\u00ed-Perez","year":"2015","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.diabres.2020.108266_b0375","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-019-1492-6","article-title":"Effect of hCMSCs and liraglutide combination in ALI through cAMP\/PKAc\/\u03b2-catenin signaling pathway","volume":"11","author":"Feng","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.diabres.2020.108266_b0380","doi-asserted-by":"crossref","first-page":"174e9","DOI":"10.4103\/ijccm.IJCCM_273_17","article-title":"Comparison of glycemic control between continuous regular insulin infusion and single-dose subcutaneous insulin glargine injection in medical critically ill patients","volume":"22","author":"Bhurayanontachai","year":"2018","journal-title":"Indian J Crit Care Med"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822720305167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822720305167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:14:43Z","timestamp":1759173283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822720305167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":76,"alternative-id":["S0168822720305167"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2020.108266","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2020.108266","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108266"}}